Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Probenecid for Opioid Withdrawal in Chronic Pain
NCT04939623Phase 2Recruiting
- Sponsor
- University of Calgary
- Start
- Oct 2023
- Primary completion
- Dec 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of probenecid in opioid withdrawal, sponsored by University of Calgary. Started Oct 2023; status: recruiting.
02
Drugs
probenecid
03
Conditions
opioid withdrawal
Beyond the preview
Go deeper on NCT04939623.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04939623.